News Focus
News Focus
icon url

Number sleven

04/15/22 3:56 PM

#374947 RE: dukesking #374945

Duke, It looks like 6 weeks ago gv sales started to decline. I didn't expect to see this. Formularies/supply? Let's hope the trend continues.
Sleven,
icon url

rafunrafun

04/15/22 4:26 PM

#374949 RE: dukesking #374945

Hikma are down over 50% since their high. Would love to know why.

Next few weeks will be big to see if Dr Reddy are going to continue their downfall - today is encouraging.

Will Apotex encounter whichever issue(s) Hikma (& Dr Reddy) encountered?
icon url

couldbebetter

04/15/22 5:38 PM

#374952 RE: dukesking #374945

Dukesking, Whatever it is I hope it continues!
I wonder if some form of digital advertising will
kick in at some point, especially if it could be
used to differentiate between branded Vascepa
and generics. Might have to wait until AMRN has
proof certain there is a difference. Sure would be
nice if Vascepa gains solid traction in the US soon!